Lipogranulomatosis Latest Advances

Find the Latest Research About Lipogranulomatosis

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications

A 3D iPSC retina model reveals non-cell-autonomous and non-neuronal mechanism of photoreceptor degeneration in a lysosomal storage disorder.

A 3D iPSC retina model reveals non-cell-autonomous and non-neuronal mechanism of photoreceptor degeneration in a lysosomal storage disorder.

Journal: bioRxiv : the preprint server for biology
Published: August 06, 2025

Farber's Lipogranulomatosis: Multimodal Therapy With Tocilizumab and Consolidative HSCT Improves Assessment, and Long-Term Outcome.

Farber's Lipogranulomatosis: Multimodal Therapy With Tocilizumab and Consolidative HSCT Improves Assessment, and Long-Term Outcome.

Journal: JIMD reports
Published: June 02, 2025

Genetic analysis of a fetus with Farber lipogranulomatosis caused by ASAH1 gene variant

Genetic analysis of a fetus with Farber lipogranulomatosis caused by ASAH1 gene variant

Journal: Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
Published: May 11, 2025

Ceramide toxicity in cardiomyocytes: from Farber disease to cardiovascular diseases.

Ceramide toxicity in cardiomyocytes: from Farber disease to cardiovascular diseases.

Journal: American journal of physiology. Heart and circulatory physiology
Published: December 20, 2024

Cardiac dysfunction and altered gene expression in acid ceramidase-deficient mice.

Cardiac dysfunction and altered gene expression in acid ceramidase-deficient mice.

Journal: American journal of physiology. Heart and circulatory physiology
Published: December 12, 2024

Therapeutic perspectives for lysosomal storage disorders caused by acid ceramidase deficiency

Therapeutic perspectives for lysosomal storage disorders caused by acid ceramidase deficiency

Journal: Medecine sciences : M/S
Published: November 18, 2024

Acid Ceramidase Deficiency: New Insights on SMA-PME Natural History, Biomarkers, and In Cell Enzyme Activity Assay.

Acid Ceramidase Deficiency: New Insights on SMA-PME Natural History, Biomarkers, and In Cell Enzyme Activity Assay.

Journal: Neurology. Genetics
Published: September 25, 2024

Novel cutaneous manifestations of a pediatric patient with Farber lipogranulomatosis.

Novel cutaneous manifestations of a pediatric patient with Farber lipogranulomatosis.

Journal: JAAD case reports
Published: August 26, 2024

Hematopoietic stem cell transplantation leads to biochemical and functional correction in two mouse models of acid ceramidase deficiency.

Hematopoietic stem cell transplantation leads to biochemical and functional correction in two mouse models of acid ceramidase deficiency.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 09, 2024

Adiponectin overexpression improves metabolic abnormalities caused by acid ceramidase deficiency but does not prolong lifespan in a mouse model of Farber Disease.

Adiponectin overexpression improves metabolic abnormalities caused by acid ceramidase deficiency but does not prolong lifespan in a mouse model of Farber Disease.

Journal: Molecular genetics and metabolism reports
Published: November 17, 2023

Acid Ceramidase Deficiency: Bridging Gaps between Clinical Presentation, Mouse Models, and Future Therapeutic Interventions.

Acid Ceramidase Deficiency: Bridging Gaps between Clinical Presentation, Mouse Models, and Future Therapeutic Interventions.

Journal: Biomolecules
Published: January 09, 2023

Skin inflammation and impaired adipogenesis in a mouse model of acid ceramidase deficiency.

Skin inflammation and impaired adipogenesis in a mouse model of acid ceramidase deficiency.

Journal: Journal of inherited metabolic disease
Published: April 17, 2022
Showing 1-12 of 87

Last Updated: 04/28/2026